To promote the growth of medical apps, the agency said that it would not enforce standards for most apps that log and track health data, since they “pose minimal risk to consumers.” Instead, those programs could likely empower Americans to better monitor their health.
However, the FDA will target apps that are intended to be used along with another medical device, or those that turn a user’s smartphone or tablet into a device that would be regulated under normal conditions.
Those devices can pose a threat if they don’t work as intended, the FDA said. For instance, an app that calculates dosage of a drug or radiation therapy could malfunction and lead to a patient receiving the wrong dose.
To make sure the tools are up to snuff, the FDA will treat those apps like any other medical device.
The 43-page guidance document released on Monday finalizes a 2011 draft that received largely positive comments from the public.
So far, the FDA has cleared almost 100 mobile medical apps, including blood pressure monitors and tools for doctors to monitor heart rate.